Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease

被引:8
作者
Jia, Jue [1 ]
Liu, Ruoshuang [1 ]
Wei, Weiping [1 ]
Yu, Fan [2 ]
Yu, Xiawen [1 ]
Shen, Yirong [1 ]
Chen, Caiqin [1 ]
Cai, Zhensheng [1 ]
Wang, Chenxi [1 ]
Zhao, Zhicong [1 ]
Wang, Dong [1 ]
Yang, Ling [1 ]
Yuan, Guoyue [1 ]
机构
[1] Jiangsu Univ, Dept Endocrinol & Metab, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[2] Jiangsu Univ, Dept Endocrinol & Metab, Jurong Hosp, Zhenjiang, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
monocyte to high-density lipoprotein cholesterol ratio (MHR); metabolic-associated fatty liver disease; type 2 diabetes mellitus; inflammatory marker; obesity; INSULIN-RESISTANCE; INFLAMMATION; SEVERITY;
D O I
10.3389/fphys.2021.762242
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Recently, monocyte to high-density lipoprotein cholesterol ratio (MHR) as a novel inflammatory biomarker has drawn lots of attention. This study was conducted in patients with type 2 diabetes mellitus (T2DM) to investigate the correlation between MHR and metabolic-associated fatty liver disease (MAFLD).Methods: Totally, 1,051 patients with T2DM from the Affiliated Hospital of Jiangsu University were enrolled and classified as MAFLD (n = 745) group and non-MAFLD (n = 306) group according to the MAFLD diagnostic criteria. In contrast, patients were also separated into four groups based on MHR quartiles. Anthropometric and biochemical measurements were performed. The visceral fat area (VFA) and subcutaneous fat area (SFA) of participants were measured by dual bioelectrical impedance. Fatty liver was assessed by ultrasonography.Results: The MHR level of subjects in the MAFLD group was statistically greater than that in the non-MAFLD group (P < 0.05). Meanwhile, MHR was higher in the overweight or obese MAFLD group compared with that in the lean MAFLD group (P < 0.05). The area under the ROC Curve (AUC) assessed by MHR was larger than that of other inflammatory markers (P < 0.01). The cutoff value of MHR was 0.388, with a sensitivity of 61.74% and a specificity of 56.54%. For further study, binary logistic regression analyses of MAFLD as a dependent variable, the relationship between MHR and MAFLD was significant (P < 0.01). After adjusting for many factors, the relationship still existed. In the four groups based on MHR quartiles, groups with higher values of MHR had a significantly higher prevalence of MAFLD (P < 0.05). The percentage of patients with obese MAFLD increased as the MHR level increased (P < 0.01). Among different quartiles of MHR, it showed that with the increasing of MHR, the percentage of patients with MAFLD who had more than four metabolic dysfunction indicators increased, which was 46.39, 60.52, 66.79, and 79.91%, respectively, in each quartile.Conclusion: Monocyte to high-density lipoprotein cholesterol ratio is a simple and practicable inflammatory parameter that could be used for assessing MAFLD in T2DM. T2DM patients with higher MHR have more possibility to be diagnosed as MAFLD. Therefore, more attention should be given to the indicator in the examination of T2DM.
引用
收藏
页数:15
相关论文
共 40 条
[1]   Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease [J].
Akboga, Mehmet Kadri ;
Balci, Kevser Gulcihan ;
Maden, Orhan ;
Ertem, Ahmet Goktug ;
Kirbas, Ozgur ;
Yayla, Cagri ;
Acar, Burak ;
Aras, Dursun ;
Kisacik, Halil ;
Aydogdu, Sinan .
BIOMARKERS IN MEDICINE, 2016, 10 (04) :375-383
[3]  
[Anonymous], 2019, LIPIDS HEALTH DIS, DOI [DOI 10.1186/s12944-019-1076-6, DOI 10.1186/S12944-019-1076-6]
[4]   Socio-economics status and metabolic syndrome: A meta-analysis [J].
Blanquet, M. ;
Legrand, A. ;
Pelissier, A. ;
Mourgues, C. .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) :1805-1812
[5]   Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes [J].
Bril, Fernando ;
McPhaul, Michael J. ;
Caulfield, Michael P. ;
Clark, Virginia C. ;
Soldevilla-Pico, Consuelo ;
Firpi-Morell, Roberto J. ;
Lai, Jinping ;
Shiffman, Dov ;
Rowland, Charles M. ;
Cusi, Kenneth .
DIABETES CARE, 2020, 43 (02) :290-297
[6]   Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome [J].
Cetin, Mehmet Serkan ;
Cetin, Elif Hande Ozcan ;
Kalender, Erol ;
Aydin, Selahattin ;
Topaloglu, Serkan ;
Kisacik, Halil Lutfi ;
Temizhan, Ahmet .
HEART LUNG AND CIRCULATION, 2016, 25 (11) :1077-1086
[7]   The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes [J].
Chen, Jia Wei ;
Li, Chang ;
Liu, Zhu Hui ;
Shen, Ying ;
Ding, Feng Hua ;
Shu, Xin Y. ;
Zhang, Rui Yan ;
Shen, Wei Feng ;
Lu, Lin ;
Wang, Xiao Qun .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[8]   Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China [J].
Chen, Tong ;
Chen, Haishan ;
Xiao, Hua ;
Tang, Hongjuan ;
Xiang, Zhicong ;
Wang, Xin ;
Wang, Xuan ;
Zou, Hequn .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 :597-605
[9]   Redefining non-alcoholic fatty liver disease: what's in a name? [J].
不详 .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05) :419-419
[10]   Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus [J].
Ferguson, Daniel ;
Finck, Brian N. .
NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (08) :484-495